Medical Advisory Board

Medical Advisory Board

Eliot Lazar, MD

Eliot Lazar, MD

Eliot Lazar, M.D., is a clinical ophthalmologist who serves as the President of El Con Medical Consulting and the Principal of ElCon Medical in Buffalo, New York. Dr. Lazar has extensive experience in the commercial side of ophthalmology and other specialties. He has worked broadly in the development of devices, therapeutics, and diagnostics, and has participated in many of the critical drug delivery advances in ophthalmology and other specialties. Dr. Lazar has also collaborated with financial institutions of all sizes and scopes on both due diligence as well as at the board of directors level. Dr. Lazar has worked collaboratively with both local and global organizations on endeavors from the pre-clinical stage through the commercial stage. Dr. Lazar holds a B.S. from the University of Pennsylvania, an M.S. in Immunology from the Royal College of Surgeons at the State University of New York, and an M.D. from Georgetown University School of Medicine.

Gerald Horn, MD

Gerald Horn, MD

Gerald Horn, M.D., the original inventor of Nyxol®, is a board-certified ophthalmologist and laser vision specialist. A pioneer in his field, Dr. Horn has dedicated his career to laser vision surgery and is trained in numerous procedures, including LASIK. Dr. Horn received his undergraduate degree from Northwestern University and his medical degree in ophthalmology from the University of Illinois Medical School. He completed an internship at Rush-Presbyterian St. Luke’s Hospital and went on to complete several mini-fellowships in LASIK, radial keratotomy, ALK, and epikeratophakia. His expertise in front-of-the-eye conditions, and passion for drug development led him to develop phentolamine mesylate ophthalmic solution (Nyxol®) and co-found Ocularis Pharma. As the founder and board member at Eye Therapeutics, he invented Lumify®, an extended-use eye whitener licensed to and sold by Bausch & Lomb. As the Chief Scientific Officer at Presbyopia Therapies, Dr. Horn invented “Liquid Vision,” an eye drop designed to temporarily restore reading vision with a recent successful Phase 2b FDA trial. As the Chief Scientific Officer at PS Therapies, he is developing a topical contact lens blister pack and disruptive OTC dry eye therapy formulations. Dr. Horn is an author on numerous patents covering a range of ophthalmic drugs and OTC products.

Marguerite McDonald, MD, FACS

Marguerite McDonald, MD, FACS

Marguerite McDonald, M.D., F.A.C.S., is a board-certified ophthalmologist. She received her medical degree from Columbia University College of Physicians and Surgeons and completed her internship at Lenox Hill Hospital, ophthalmology residency at Manhattan Eye Ear and Throat Hospital/Cornell, and a fellowship in corneal and external diseases at the LSU Eye Center. From 1993 to 2005, Dr. McDonald served as the director of the Southern Vision Institute in New Orleans. She is a clinical professor of ophthalmology at the NYU School of Medicine and an adjunct clinical professor of ophthalmology at Tulane University Health Sciences Center. Dr. McDonald was a professor of ophthalmology and the director of the Corneal Service at the LSU Eye Center, LSU Medical Center School of Medicine. She performed the world’s first excimer laser treatment to eliminate or reduce the need for glasses and contact lenses as well as the world’s first excimer laser surgeries for farsightedness. She was also the first North American surgeon to perform Epi-LASIK. Dr. McDonald also performed the first EBK procedure (epi-Bowman’s keratectomy) in the Americas. Dr. McDonald has over 1,500 publications, has received many awards, and has served on the editorial boards of several publications, including the Journal of Cataract and Refractive Surgery and the Journal of Refractive Surgery. She was elected the first female president of the American Society of Cataract and Refractive Surgery (ASCRS) for the 2002-03 term. In 2009-10, Dr. McDonald served as the first female president of the International Society of Refractive Surgery of the American Academy of Ophthalmology (ISRS/AAO). 

Thomas W. Samuelson, MD

Thomas W. Samuelson, MD

Thomas W. Samuelson, M.D., is a board-certified ophthalmologist who specializes in the treatment of glaucoma, cataract, and refractive surgery, as well as a founding partner and attending surgeon of Minnesota Eye Consultants. Dr. Samuelson completed his medical degree at the University of Minnesota, his residency training at the University of South Florida where he served as chief resident, and his sub-specialty training at the Wills Eye Hospital in Philadelphia. Dr. Samuelson is an adjunct professor of ophthalmology at the University of Minnesota and past chairman of the medical staff at the Phillips Eye Institute in Minneapolis. Dr. Samuelson is the current president of the American Society of Cataract and Refractive Surgery. He is the recipient of the American Academy of Ophthalmology’s Junior and Senior Achievement Awards honoring contributions made to the Academy’s educational programs. In 2018, Dr. Samuelson was awarded the AAO Lifetime Achievement Award. He also received the “Secretariate Award” for contributions to the AAO annual meeting. Dr. Samuelson has served as an examiner for the American Board of Ophthalmology and has been named as one of America’s Top Doctors each year since 2002. Dr. Samuelson served on the executive committee of the American Glaucoma Society for nearly a decade. As a member of the Basic Clinical Science Course Committee for the AAO, Dr. Samuelson helped to write the textbooks most studied by residents within the field of ophthalmology. Dr. Samuelson is the glaucoma section editor for Ocular Surgery News and serves as editorial board member and scientific reviewer for several other ophthalmology journals.

Edward Holland, MD

Edward Holland, MD

Edward Holland, M.D., is the Director of Cornea Services at Cincinnati Eye Institute and a professor of ophthalmology at the University of Cincinnati. Dr. Holland is internationally known for his knowledge and expertise in the field of cornea and external diseases. Dr. Holland is the author of over 270 articles in peer-reviewed journals and has co-edited four editions of Cornea, the most widely read textbook on corneal disease and surgery. He attended the Loyola-Medical School in Chicago and trained in Ophthalmology at the University of Minnesota. He completed a fellowship in cornea and external disease at the University of Iowa, and then a second fellowship in ocular immunology at the National Eye Institute. Dr. Holland was a former member of the Board of Trustees for the American Academy of Ophthalmology and received both the Senior Achievement Award and Life Achievement Honor Award from the AAO. He also served as the President of American Society of Cataract and Refractive Surgery and presently serves as the Program Chair.

Richard Lindstrom, MD

Richard Lindstrom, MD

Richard L. Lindstrom, M.D., is a board-certified ophthalmologist and internationally-recognized leader in corneal, cataract, refractive and laser surgery. Dr. Lindstrom is the founder of and attending surgeon at Minnesota Eye Consultants and an adjunct professor emeritus at the University of Minnesota, Department of Ophthalmology. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly-acclaimed physician and surgeon. After graduating magna cum laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972. Dr. Lindstrom holds over 38 patents in ophthalmology and has developed a number of solutions, intraocular lenses and instruments that are used in clinical practices globally. Dr. Lindstrom is a frequent lecturer on external diseases, cataract, refractive surgery, and glaucoma; he has presented over 40 named lectures and keynote speeches to professional societies throughout the world. He has co-edited ten books and published over 350 peer-reviewed journal articles and 60 book chapters.

Jay Pepose, MD

Jay Pepose, MD

Jay S. Pepose, M.D., Ph.D, is the founder and the current Medical Director of the Pepose Vision Institute. He also founded the Midwest Corneal Research Foundation, now the Lifelong Vision Foundation, as an independent offshoot of the Pepose Vision Institute. He is also a professor of clinical ophthalmology and visual sciences at Washington University School of Medicine in St. Louis. Dr. Pepose is a specialist in refractive surgery and corneal and external diseases. He is a consultant to the Centers for Disease Control and Prevention. Dr. Pepose is actively involved in clinical research trials and has been the recipient of R-01 grant support from the National Eye Institute. Dr. Pepose has served on the editorial board of several prestigious journals, including American Journal of Ophthalmology, Investigative Ophthalmology & Visual Science (IOVS), Cornea, and The Journal of Refractive Surgery. Dr. Pepose has published over 160 peer-reviewed articles and a book on ocular infections and inflammatory diseases. Dr. Pepose received an A.B. and M.A. in neurophysiology from Brandeis University and completed the M.D.-Ph.D. program at the UCLA School of Medicine. He completed his ophthalmology residency at the Wilmer Institute at the Johns Hopkins Medical Center and his fellowship training at Georgetown University Medical Center.

David Boyer, MD

David Boyer, MD

David S. Boyer, M.D., is a board-certified ophthalmologist specializing in treatment of retinal and vitreous diseases. He is a Senior Partner at Retina-Vitreous Associates Medical Group. Dr. Boyer earned his medical degree at Chicago Medical School, completed his internship and residency at the University of Southern California/Los Angeles County Medical Center, and completed his fellowship in retinal surgery at the Wills Eye Hospital in Philadelphia. Dr. Boyer is a clinical professor of ophthalmology at the Keck School of Medicine of the University of Southern California and has an extensive research background. He is one of the leading retinal clinical researchers in the country for new treatments in macular degeneration and diabetic macular edema. Dr. Boyer is a widely-published author and avid lecturer, who lectures internationally on retinal research and innovative approaches to the treatment of retinal disease. He has authored and co-authored numerous works in peer-reviewed journals and served as a reviewer for ophthalmology and diabetes medical publications, including Archives of Ophthalmology, American Journal of Ophthalmology, and Ophthalmology.

Jack Holladay, MD, MSEE, FACS

Jack Holladay, MD, MSEE, FACS

Jack T. Holladay, M.D., F.A.C.S., is a board-certified ophthalmologist and a clinical professor of ophthalmology at Baylor College of Medicine. Dr. Holladay has authored three books and hundreds of chapters and articles in peer-reviewed scientific journals, serves on several editorial, medical, and scientific advisory boards, and holds numerous patents. Dr. Holladay was inducted into the Hall of Fame of the American Society of Cataract and Refractive Surgery in 2012. He is currently the Chair of the FDA/American Academy of Ophthalmology Task Force charged with developing guidelines for accommodating and extended depth of focus (EDOF) intraocular lenses (IOLs). Dr. Holladay received his medical degree and  the Distinguished Alumnus Award from the University of Texas and his bachelor’s and master’s degrees in Electrical Engineering from Southern Methodist University.

Paul Karpecki, OD, FAAO

Paul Karpecki, OD, FAAO

Paul Karpecki, D.O., FAAO, is a leader and pioneer in optometry and has authored over a thousand papers about dry eye disease. In 2003, he was appointed to the Delphi International Society at Wilmer-Johns Hopkins, which put him in the company of the world’s top 25 dry eye experts. Dr. Karpecki currently serves as the Chief Clinical Editor for Review of Optometry, the magazine read most by optometrists. He is the Director of Clinical Content and Chairman of the New Technologies & Treatment in Eye Care series, and serves on the board for the charitable organization Optometry Giving Sight. Dr. Karpecki has also served as Co-Chair for the Dry Eye Summit; Co-Chair for [email protected] Meeting; Co-Chair of the Tear Film and Ocular Surface Society Symposium in 2016 in Montpellier, France; Director for the CJO Optometric Dry Eye Guidelines for EyeCare; and a committee member for the DEWS II Diagnostic sub-committee. Dr. Karpecki received his Doctor of Optometry degree from Indiana University before completing a fellowship in medical cornea and refractive surgery at the Pennsylvania College of Optometry. In addition to his work as an optometrist at Gaddie Eye Centers, he also currently serves as Clinical Director of Advanced Ocular Surface Disease at Kentucky Eye Institute.